Fatal bleeding rare with extended dual antiplatelet therapy

Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1VrX1MF

No comments:

Post a Comment